Investigation of magnetization transfer ratio-derived pial and subpial abnormalities in the multiple sclerosis spinal cord.

Neuropathological studies in multiple sclerosis have suggested that meningeal inflammation in the brain may be linked to disease progression. Inflammation in the spinal cord meninges has been associated with axonal loss, a pathological substrate for disability. Quantitative magnetic resonance imaging facilitates the investigation of spinal cord microstructure by approximating histopathological changes. We acquired structural and quantitative imaging of the cervical spinal cord from which we calculated magnetization transfer ratio in the outer spinal cord-an area corresponding to the expected location of the pia mater and subpial region-and in spinal cord white and grey matter. We studied 26 healthy controls, 22 people with a clinically isolated syndrome, 29 with relapsing-remitting, 28 with secondary-progressive and 28 with primary-progressive multiple sclerosis. Magnetization transfer ratio values in the outermost region of the spinal cord were higher than the white matter in controls and patients: controls (51.35 ± 1.29 versus 49.87 ± 1.45, P < 0.01), clinically isolated syndrome (50.46 ± 1.39 versus 49.13 ± 1.19, P < 0.01), relapsing-remitting (48.86 ± 2.89 versus 47.44 ± 2.70, P < 0.01), secondary-progressive (46.33 ± 2.84 versus 44.75 ± 3.10, P < 0.01) and primary-progressive multiple sclerosis (46.99 ± 3.78 versus 45.62 ± 3.40, P < 0.01). In linear regression models controlling for cord area and age, higher outer spinal cord magnetization transfer ratio values were seen in controls than all patient groups: clinically isolated syndrome (coefficient = -0.32, P = 0.03), relapsing-remitting (coefficient = -0.48, P < 0.01), secondary-progressive (coefficient = -0.51, P < 0.01) and primary-progressive multiple sclerosis (coefficient = -0.38, P < 0.01). In a regression analysis correcting for age and cord area, magnetization transfer ratio values in the outer cord were lower in relapsing-remitting multiple sclerosis compared with clinically isolated syndrome (coefficient = -0.28, P = 0.02), and both primary and secondary-progressive compared to relapsing-remitting multiple sclerosis (coefficients = -0.29 and -0.24, respectively, P = 0.02 for both). In the clinically isolated syndrome and relapsing-remitting multiple sclerosis groups, outer cord magnetization transfer ratio was decreased in the absence of significant cord atrophy. In a multivariate regression analysis an independent association was seen between outer cord magnetization transfer ratio and cord atrophy (coefficient = 0.40, P < 0.01). Our in vivo imaging observations suggest that abnormalities in a region involving the pia mater and subpial cord occur early in the course of multiple sclerosis and are more marked in those with a progressive course.

[1]  Jeffrey A. Cohen,et al.  Defining the clinical course of multiple sclerosis: the 2013 revisions. , 2014, Neurology.

[2]  Julien Cohen-Adad,et al.  Nineteen‐channel receive array and four‐channel transmit array coil for cervical spinal cord imaging at 7T , 2014, Magnetic resonance in medicine.

[3]  Varun Sethi,et al.  Investigation of outer cortical magnetisation transfer ratio abnormalities in multiple sclerosis clinical subgroups , 2014, Multiple sclerosis.

[4]  Julien Cohen-Adad,et al.  The current state-of-the-art of spinal cord imaging: Methods , 2014, NeuroImage.

[5]  Arunesh Mittal,et al.  Casting light on multiple sclerosis heterogeneity: the role of HLA-DRB1 on spinal cord pathology. , 2013, Brain : a journal of neurology.

[6]  Jerry L Prince,et al.  Multiparametric MRI correlates of sensorimotor function in the spinal cord in multiple sclerosis , 2013, Multiple sclerosis.

[7]  Elizabeth Fisher,et al.  Clinically feasible MTR is sensitive to cortical demyelination in MS , 2013, Neurology.

[8]  F. Barkhof,et al.  Spinal cord lesions in patients with clinically isolated syndrome , 2013, Neurology.

[9]  Katie Lidster,et al.  Reproducibility: Research-reporting standards fall short , 2012, Nature.

[10]  David H. Miller,et al.  Feasibility of grey matter and white matter segmentation of the upper cervical cord in vivo: A pilot study with application to magnetisation transfer measurements , 2012, NeuroImage.

[11]  R. Reynolds,et al.  Meningeal inflammation plays a role in the pathology of primary progressive multiple sclerosis. , 2012, Brain : a journal of neurology.

[12]  R. Bakshi,et al.  Approaches to Normalization of Spinal Cord Volume: Application to Multiple Sclerosis , 2012, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[13]  B. Scheithauer,et al.  Inflammatory cortical demyelination in early multiple sclerosis. , 2011, The New England journal of medicine.

[14]  David H. Miller,et al.  Improved MRI quantification of spinal cord atrophy in multiple sclerosis , 2011, Journal of magnetic resonance imaging : JMRI.

[15]  R. Reynolds,et al.  Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis. , 2011, Brain : a journal of neurology.

[16]  W. Brück,et al.  Axonal Loss and Neurofilament Phosphorylation Changes Accompany Lesion Development and Clinical Progression in Multiple Sclerosis , 2011, Brain pathology.

[17]  Jeffrey A. Cohen,et al.  Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria , 2011, Annals of neurology.

[18]  D. Hafler,et al.  Related B cell clones populate the meninges and parenchyma of patients with multiple sclerosis. , 2011, Brain : a journal of neurology.

[19]  R. Reynolds,et al.  Meningeal T cells associate with diffuse axonal loss in multiple sclerosis spinal cords , 2010, Annals of neurology.

[20]  R. Reynolds,et al.  A Gradient of neuronal loss and meningeal inflammation in multiple sclerosis , 2010, Annals of neurology.

[21]  David H. Miller,et al.  Reducing the impact of white matter lesions on automated measures of brain gray and white matter volumes , 2010, Journal of magnetic resonance imaging : JMRI.

[22]  M. A. Horsfield,et al.  Rapid semi-automatic segmentation of the spinal cord from magnetic resonance images: Application in multiple sclerosis , 2010, NeuroImage.

[23]  David H. Miller,et al.  High field (9.4 Tesla) magnetic resonance imaging of cortical grey matter lesions in multiple sclerosis. , 2010, Brain : a journal of neurology.

[24]  R. Ransohoff Immunology: In the beginning , 2009, Nature.

[25]  F. X. Aymerich,et al.  A single-center, randomized, double-blind, placebo-controlled study of interferon beta-1b on primary progressive and transitional multiple sclerosis , 2009, Multiple sclerosis.

[26]  David H. Miller,et al.  Imaging outcomes for neuroprotection and repair in multiple sclerosis trials , 2009, Nature Reviews Neurology.

[27]  Eliza M. Gordon-Lipkin,et al.  Sensorimotor dysfunction in multiple sclerosis and column-specific magnetization transfer-imaging abnormalities in the spinal cord. , 2009, Brain : a journal of neurology.

[28]  Hans Lassmann,et al.  The relation between inflammation and neurodegeneration in multiple sclerosis brains , 2009, Brain : a journal of neurology.

[29]  M. Krumbholz,et al.  Compartmentalization of inflammation in the CNS: A major mechanism driving progressive multiple sclerosis , 2008, Journal of the Neurological Sciences.

[30]  S. Schoenberg,et al.  Artifacts in 3-T MRI: physical background and reduction strategies. , 2008, European journal of radiology.

[31]  A. Thompson,et al.  Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis. , 2008, Brain : a journal of neurology.

[32]  Chiara Romualdi,et al.  Detection of cortical inflammatory lesions by double inversion recovery magnetic resonance imaging in patients with multiple sclerosis. , 2007, Archives of neurology.

[33]  M. Filippi,et al.  Associations between cervical cord gray matter damage and disability in patients with multiple sclerosis. , 2007, Archives of neurology.

[34]  P. Sawchenko,et al.  Time course and distribution of inflammatory and neurodegenerative events suggest structural bases for the pathogenesis of experimental autoimmune encephalomyelitis , 2007, The Journal of comparative neurology.

[35]  P. Matthews,et al.  Neocortical neuronal, synaptic, and glial loss in multiple sclerosis , 2006, Neurology.

[36]  M Filippi,et al.  Cervical cord magnetization transfer ratio and clinical changes over 18 months in patients with relapsing-remitting multiple sclerosis: a preliminary study , 2006, Multiple sclerosis.

[37]  M. Esiri,et al.  The contribution of demyelination to axonal loss in multiple sclerosis. , 2006, Brain : a journal of neurology.

[38]  S. Vukusic,et al.  Accumulation of irreversible disability in multiple sclerosis: From epidemiology to treatment , 2006, Clinical Neurology and Neurosurgery.

[39]  G J Barker,et al.  Magnetization transfer histograms in clinically isolated syndromes suggestive of multiple sclerosis. , 2005, Brain : a journal of neurology.

[40]  Roberto Mutani,et al.  Grey Matter Pathology in Multiple Sclerosis , 2005, Journal of neuropathology and experimental neurology.

[41]  Hans Lassmann,et al.  Cortical demyelination and diffuse white matter injury in multiple sclerosis. , 2005, Brain : a journal of neurology.

[42]  Frederik Barkhof,et al.  Cortical lesions in multiple sclerosis: combined postmortem MR imaging and histopathology. , 2005, AJNR. American journal of neuroradiology.

[43]  P. Morgan,et al.  Measurement of cervical spinal cord cross‐sectional area by MRI using edge detection and partial volume correction , 2005, Journal of magnetic resonance imaging : JMRI.

[44]  Bertrand Audoin,et al.  Magnetic resonance study of the influence of tissue damage and cortical reorganization on PASAT performance at the earliest stage of multiple sclerosis , 2005, Human brain mapping.

[45]  A. Rosenwald,et al.  BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma , 2005, The Journal of experimental medicine.

[46]  M. Esiri,et al.  Pathological study of spinal cord atrophy in multiple sclerosis suggests limited role of local lesions. , 2004, Brain : a journal of neurology.

[47]  L. L. Cook,et al.  In vivo 4.0‐T magnetic resonance investigation of spinal cord inflammation, demyelination, and axonal damage in chronic‐progressive experimental allergic encephalomyelitis , 2004, Journal of magnetic resonance imaging : JMRI.

[48]  David H. Miller,et al.  Magnetization transfer ratio and myelin in postmortem multiple sclerosis brain , 2004, Annals of neurology.

[49]  J. de Andrés,et al.  Ultrastructural Findings in Human Spinal Pia Mater in Relation to Subarachnoid Anesthesia , 2004, Anesthesia and analgesia.

[50]  M. Esiri,et al.  Axonal loss in multiple sclerosis: a pathological survey of the corticospinal and sensory tracts. , 2004, Brain : a journal of neurology.

[51]  B. Serafini,et al.  Detection of Ectopic B‐cell Follicles with Germinal Centers in the Meninges of Patients with Secondary Progressive Multiple Sclerosis , 2004, Brain pathology.

[52]  M. Filippi,et al.  A preliminary diffusion tensor and magnetization transfer magnetic resonance imaging study of early-onset multiple sclerosis. , 2004, Archives of neurology.

[53]  C. Tench,et al.  Spinal cord atrophy and disability in multiple sclerosis over four years: application of a reproducible automated technique in monitoring disease progression in a cohort of the interferon β-1a (Rebif) treatment trial , 2003, Journal of neurology, neurosurgery, and psychiatry.

[54]  B. Trapp,et al.  Subpial Demyelination in the Cerebral Cortex of Multiple Sclerosis Patients , 2003, Journal of neuropathology and experimental neurology.

[55]  D. Miller,et al.  Interferon β-1a in primary progressive MS , 2003, Neurology.

[56]  F. Barkhof,et al.  The effect of the neuroprotective agent riluzole on MRI parameters in primary progressive multiple sclerosis: a pilot study , 2002, Multiple sclerosis.

[57]  M. Rudin,et al.  Quantitative and qualitative assessment of articular cartilage in the goat knee with magnetization transfer imaging. , 2001, Magnetic resonance imaging.

[58]  B. Trapp,et al.  Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions , 2001, Annals of neurology.

[59]  S. Lange,et al.  Adjusting for multiple testing--when and how? , 2001, Journal of clinical epidemiology.

[60]  C. Poser,et al.  Diagnostic criteria for multiple sclerosis , 2001, Clinical Neurology and Neurosurgery.

[61]  Moses Rodriguez,et al.  Axonal loss results in spinal cord atrophy, electrophysiological abnormalities and neurological deficits following demyelination in a chronic inflammatory model of multiple sclerosis. , 2000, Brain : a journal of neurology.

[62]  Nikos Evangelou,et al.  Quantitative pathological evidence for axonal loss in normal appearing white matter in multiple sclerosis , 2000, Annals of neurology.

[63]  M. Palkovits,et al.  Axonal changes in chronic demyelinated cervical spinal cord plaques. , 2000, Brain : a journal of neurology.

[64]  Ganter,et al.  Spinal cord axonal loss in multiple sclerosis: a post‐mortem study , 1999, Neuropathology and applied neurobiology.

[65]  S. Reingold,et al.  The Multiple Sclerosis Functional Composite measure (MSFC): an integrated approach to MS clinical outcome assessment , 1999, Multiple sclerosis.

[66]  R. Waters,et al.  International Standards for Neurological and Functional Classification of Spinal Cord Injury , 1997, Spinal Cord.

[67]  Jayaram K. Udupa,et al.  Relative Fuzzy Connectedness and Object Definition: Theory, Algorithms, and Applications in Image Segmentation , 2002, IEEE Trans. Pattern Anal. Mach. Intell..

[68]  S. Reingold,et al.  Defining the clinical course of multiple sclerosis , 1996, Neurology.

[69]  W. Donovan,et al.  The International Standards Booklet for Neurological and Functional Classification of Spinal Cord Injury , 1994, Paraplegia.

[70]  R I Grossman,et al.  Experimental allergic encephalomyelitis and multiple sclerosis: lesion characterization with magnetization transfer imaging. , 1992, Radiology.

[71]  J. Kurtzke Rating neurologic impairment in multiple sclerosis , 1983, Neurology.

[72]  D. Oppenheimer,et al.  THE CERVICAL CORD IN MULTIPLE SCLEROSIS , 1978, Neuropathology and applied neurobiology.

[73]  B. Brownell,et al.  The distribution of plaques in the cerebrum in multiple sclerosis , 1962, Journal of neurology, neurosurgery, and psychiatry.

[74]  J. Millen,et al.  On the nature of the pia mater. , 1961, Brain : a journal of neurology.

[75]  A. Elster Artifacts in 3-T MRI: Physical background and reduction strategies , 2009 .

[76]  B. Trapp,et al.  Imaging correlates of leukocyte accumulation and CXCR4/CXCL12 in multiple sclerosis. , 2009, Archives of neurology.

[77]  R. Reynolds,et al.  Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. , 2007, Brain : a journal of neurology.

[78]  Frederik Barkhof,et al.  Lack of correlation between cortical demyelination and white matter pathologic changes in multiple sclerosis. , 2007, Archives of neurology.

[79]  A. Mouritzen Dam Shrinkage of the brain during histological procedures with fixation in formaldehyde solutions of different concentrations. , 1979, Journal fur Hirnforschung.

[80]  A. MouritzenDam Shrinkage of the brain during histological procedures with fixation in formaldehyde solutions of different concentrations. , 1979 .

[81]  J. Dawson,et al.  XVIII.–The Histology of Disseminated Sclerosis , 1916, Transactions of the Royal Society of Edinburgh.